153 related articles for article (PubMed ID: 2652548)
1. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
Santelli G; Hiesse C; Schovaert D; Fassi-Fihri S; Lantz O; Bensadoun H; Benoit G; Charpentier B; Martin E; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
[No Abstract] [Full Text] [Related]
2. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
[No Abstract] [Full Text] [Related]
3. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
4. Low-dose cyclosporine or azathioprine one year after renal transplantation.
Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
[No Abstract] [Full Text] [Related]
5. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
6. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
[No Abstract] [Full Text] [Related]
7. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
[No Abstract] [Full Text] [Related]
8. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
[No Abstract] [Full Text] [Related]
9. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
10. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
Rao KV; Andersen RC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
[No Abstract] [Full Text] [Related]
11. Overcoming early cyclosporine nephrotoxicity after liver transplantation.
Burdick JF; Colombani PM; Pitt HA; Perler BA; Merritt WT; Crandall BC; Mitchell MC; Herlong HF; Williams GM
Transplant Proc; 1989 Feb; 21(1 Pt 2):2236-7. PubMed ID: 2652724
[No Abstract] [Full Text] [Related]
12. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
[No Abstract] [Full Text] [Related]
13. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
[No Abstract] [Full Text] [Related]
14. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
15. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
16. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
[No Abstract] [Full Text] [Related]
17. Renal graft histology in patients treated with different doses of cyclosporine.
Wilczek HE; Bohman SO; Groth CG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
[No Abstract] [Full Text] [Related]
18. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
[No Abstract] [Full Text] [Related]
19. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
[No Abstract] [Full Text] [Related]
20. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
Gonwa TA; Nghiem DD; Corry RJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
[No Abstract] [Full Text] [Related]
[Next] [New Search]